Schubert David R
Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037-1099, USA.
J Med Food. 2008 Dec;11(4):601-5. doi: 10.1089/jmf.2008.0094.
Among the next generation of genetically modified (GM) plants are those that are engineered to produce elevated levels of nutritional molecules such as vitamins, omega-3 fatty acids, and amino acids. Based upon the U.S. current regulatory scheme, the plants and their products may enter our food supply without any required safety testing. The potential risks of this type of GM plant are discussed in the context of human health, and it is argued that there should be very careful safety testing of plants designed to produce biologically active molecules before they are commercially grown and consumed. This will require a mandatory, scientifically rigorous review process.
下一代转基因植物中，有一些经过基因工程改造，能产生更高水平的营养分子，如维生素、omega-3脂肪酸和氨基酸。根据美国现行监管方案，这些植物及其产品无需经过任何必要的安全测试就能进入我们的食品供应。本文在人类健康背景下讨论了这类转基因植物的潜在风险，并认为在旨在生产生物活性分子的植物商业化种植和消费之前，应该进行非常严格的安全测试。这将需要一个强制性的、科学严谨的审查程序。
